Deltagen: Knockout analysis By Ilan Zipkin
Staff Writer

The next generation of platform companies to exploit the genomics explosion will have to develop target validation technology that is faster, more selective and more informative than established functional genomics approaches in order to carve out a market niche. Deltagen Inc. hopes to provide all of those advantages with its knockout mice.